Literature DB >> 8335895

Detection of glycosylation abnormality in rheumatoid IgG using N-acetylglucosamine-specific Psathyrella velutina lectin.

N Tsuchiya1, T Endo, K Matsuta, S Yoshinoya, F Takeuchi, Y Nagano, M Shiota, K Furukawa, N Kochibe, K Ito.   

Abstract

Although the galactose deficiency in the Asn297-linked sugar chains of serum IgG from patients with rheumatoid arthritis (RA) has been established, structural analysis of sugar chains has not been readily available. Psathyrella velutina lectin (PVL) preferentially interacts with the N-acetylglucosamine beta 1-->2Man group, exposed at the termini of sugar chains in agalacto IgG. Biotinylated PVL reacted strongly in Western blotting with H chains of IgG derived from patients with RA. An ELISA-based assay for the detection of agalacto IgG was developed using recombinant protein G and biotinylated PVL in combination, and the screening of patients' sera was performed. PVL binding of serum IgG significantly correlated with percentage of galactose-deficient IgG determined by the structural analysis. Age-related slight increase in PVL binding was observed among normal controls. Patients with RA showed significantly higher PVL binding (37.90 +/- 42.25 U/ml, n = 93) as compared with normal controls (5.75 +/- 2.92 U/ml, n = 112) (p = 0.0001). Patients with SLE showed lower but still significant PVL binding (17.86 +/- 5.18 U/ml, n = 10, p = 0.0001). PVL binding correlated with C-reactive protein level in serial analysis of individual RA patients, and was significantly higher in the synovial fluid compared with paired serum samples. PVL binding assay may provide an ideal tool for the simple and sensitive detection of agalacto IgG.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335895

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.

Authors:  Jennifer S Moore; Rose Kulhavy; Milan Tomana; Zina Moldoveanu; Hitoshi Suzuki; Rhubell Brown; Stacy Hall; Mogens Kilian; Knud Poulsen; Jiri Mestecky; Bruce A Julian; Jan Novak
Journal:  Mol Immunol       Date:  2007-02-02       Impact factor: 4.407

Review 2.  A retrospective and prospective view of glycopathology.

Authors:  A Kobata
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

3.  Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum.

Authors:  E Yamada; Y Tsukamoto; R Sasaki; K Yagyu; N Takahashi
Journal:  Glycoconj J       Date:  1997-04       Impact factor: 2.916

4.  Analysis of agalacto-IgG in rheumatoid arthritis using surface plasmon resonance.

Authors:  M Liljeblad; A Lundblad; P Påhlsson
Journal:  Glycoconj J       Date:  2000-05       Impact factor: 2.916

Review 5.  A journey to the world of glycobiology.

Authors:  A Kobata
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

6.  Galactosylation of IgG from rheumatoid arthritis (RA) patients--changes during therapy.

Authors:  Marta Pasek; Maria Duk; Maria Podbielska; Renata Sokolik; Jacek Szechiński; Elwira Lisowska; Hubert Krotkiewski
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

7.  Abnormal glycosylation of serum IgG in patients with IgA nephropathy.

Authors:  Hideki Homma; Keiichi Tozawa; Takahiro Yasui; Yasunori Itoh; Yutaro Hayashi; Kenjiro Kohri
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

8.  Comparison of lectin-binding patterns between young adults and older rat glycoproteins in the brain.

Authors:  Y Sato; M Kimura; T Endo
Journal:  Glycoconj J       Date:  1998-12       Impact factor: 2.916

9.  Glycosylation and Aging.

Authors:  Ana Cindrić; Jasminka Krištić; Marina Martinić Kavur; Marija Pezer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

10.  Glycobiology: 'the function of sugar in the IgG molecule'.

Authors:  R A Dwek; A C Lellouch; M R Wormald
Journal:  J Anat       Date:  1995-10       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.